Company profile: Triomics
1.1 - Company Overview
Company description
- Provider of an oncology-focused generative AI platform for clinical trial matching. Offers OncoLLM to process clinical and genomic data; Prism for EHR-integrated trial matching; Harmony for EHR data curation for tumor registries and precision oncology; Symphony to streamline care via triage, identifying missing data, and pre-charting; and Clinical Navigators for clinical workflow integration, trial navigation, and registry engagement.
Products and services
- Prism: An EHR-integrated platform powered by OncoLLM that facilitates high-accuracy patient-to-trial matching for clinical trial enrollment, integrating matching workflows with electronic health records
- OncoLLM: An oncology-specific AI model engineered to process clinical and genomic data within healthcare institutions' firewalls, delivering high-accuracy analysis for oncology use cases
- Harmony: An EHR-focused data curation tool that uses OncoLLM to assist workflows such as data curation for tumor registries and precision oncology initiatives, structuring patient information for registry engagement
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Triomics
SnapGene
HQ: United States
Website
- Description: Provider of software to plan, visualize, and document DNA cloning and PCR.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SnapGene company profile →
HMD Clinical
HQ: United Kingdom
Website
- Description: Provider of technology outsourcing services specializing in applications and databases for clinical trials, offering a unique blend of analytical skills, in-depth IT expertise, and clinical trial experience, focused on efficient, cost-effective solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HMD Clinical company profile →
Cellares
HQ: United States
Website
- Description: Provider of automated cell therapy manufacturing solutions, including the Cell Shuttle—a fully closed, high-throughput platform integrating all unit operations; Smart Factories for mass manufacturing; a Technology Adoption Program to automate and transfer developer processes; process and analytical development services; and clinical and commercial cGMP manufacturing through a global network of IDMO Smart Factories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellares company profile →
Allcyte
HQ: Austria
Website
- Description: Provider of functional drug testing in primary human material using the Pharmacoscopy high-content imaging platform and AI-supported image analysis pipelines to advance precision and personalized medicine for cancer patients and treating physicians, while supporting pharmaceutical companies in drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allcyte company profile →
BSSN Software
HQ: Germany
Website
- Description: Provider of vendor-independent laboratory informatics enabling easy access, integration, and sharing of scientific data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BSSN Software company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Triomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Triomics
2.2 - Growth funds investing in similar companies to Triomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Triomics
4.2 - Public trading comparable groups for Triomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →